Kalvista Pharmaceuticals Inc
NASDAQ:KALV

Watchlist Manager
Kalvista Pharmaceuticals Inc Logo
Kalvista Pharmaceuticals Inc
NASDAQ:KALV
Watchlist
Price: 15.23 USD 1.53% Market Closed
Market Cap: 769.9m USD

Intrinsic Value

The intrinsic value of one KALV stock under the Base Case scenario is 11.31 USD. Compared to the current market price of 15.23 USD, Kalvista Pharmaceuticals Inc is Overvalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KALV Intrinsic Value
11.31 USD
Overvaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Kalvista Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about KALV?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is KALV valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Kalvista Pharmaceuticals Inc.

Explain Valuation
Compare KALV to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about KALV?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kalvista Pharmaceuticals Inc

Current Assets 325.2m
Cash & Short-Term Investments 309.2m
Receivables 7.1m
Other Current Assets 8.9m
Non-Current Assets 14.7m
PP&E 12.3m
Other Non-Current Assets 2.4m
Current Liabilities 45.1m
Accounts Payable 8.1m
Accrued Liabilities 22.2m
Other Current Liabilities 14.8m
Non-Current Liabilities 277.9m
Long-Term Debt 268.7m
Other Non-Current Liabilities 9.1m
Efficiency

Free Cash Flow Analysis
Kalvista Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Kalvista Pharmaceuticals Inc

Revenue
15.1m USD
Cost of Revenue
-1.8m USD
Gross Profit
13.3m USD
Operating Expenses
-118.4m USD
Operating Income
-105.1m USD
Other Expenses
-4.5m USD
Net Income
-109.6m USD
Fundamental Scores

KALV Profitability Score
Profitability Due Diligence

Kalvista Pharmaceuticals Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Sustainable 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
16/100
Profitability
Score

Kalvista Pharmaceuticals Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

KALV Solvency Score
Solvency Due Diligence

Kalvista Pharmaceuticals Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
High D/E
42/100
Solvency
Score

Kalvista Pharmaceuticals Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KALV Price Targets Summary
Kalvista Pharmaceuticals Inc

Wall Street analysts forecast KALV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KALV is 31.62 USD with a low forecast of 22.22 USD and a high forecast of 40.95 USD.

Lowest
Price Target
22.22 USD
46% Upside
Average
Price Target
31.62 USD
108% Upside
Highest
Price Target
40.95 USD
169% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Kalvista Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for KALV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

KALV Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one KALV stock?

The intrinsic value of one KALV stock under the Base Case scenario is 11.31 USD.

Is KALV stock undervalued or overvalued?

Compared to the current market price of 15.23 USD, Kalvista Pharmaceuticals Inc is Overvalued by 26%.

Back to Top